Internal Medicine, Pulmonary Disease · Springfield, MO
NPI
1477591303
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
3800 S National Ave Ste 510
Springfield, MO, 65807
Phone (417) 875-3411
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
1,938 services
Medicare patients, 2024
1,050
Average age 72
Drug cost, 2024
$1.2M
1,350 prescriptions
Company payments, 2025
$1,002
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Terrence D Coulter was code 99291 (critical care e&m), 229 times for 93 patients. In total Terrence D Coulter billed 1,938 services in 40 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 229 | 93 | $157.44 | $36K |
| 95811 Sleep Study | Facility | 197 | 183 | $83.55 | $16K |
| 94729 Pulmonary Function Testing | Facility | 192 | 190 | $6.49 | $1,247 |
| 95810 Sleep Study | Facility | 189 | 178 | $81.33 | $15K |
| 95806 Sleep Study | Facility | 179 | 176 | $28.46 | $5,094 |
| 94727 Pulmonary Function Testing | Facility | 156 | 154 | $8.71 | $1,359 |
| 94060 Pulmonary Function Testing | Facility | 135 | 135 | $7.54 | $1,018 |
| 99233 Hospital E&M - Subsequent | Facility | 93 | 57 | $87.47 | $8,135 |
| 99214 Office E&M - Established | Facility | 76 | 68 | $68.79 | $5,228 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 66 | 66 | $32.24 | $2,128 |
| 94010 Pulmonary Function Testing | Facility | 63 | 63 | $5.90 | $372 |
| 99232 Hospital E&M - Subsequent | Facility | 59 | 34 | $58.59 | $3,457 |
| 99213 Office E&M - Established | Facility | 52 | 50 | $35.05 | $1,822 |
| 94726 Pulmonary Function Testing | Facility | 31 | 31 | $8.91 | $276 |
| 99214 Office E&M - Established | Office | 24 | 23 | $93.12 | $2,235 |
By year: 2022 $92K for 1,256 services; 2023 $91K for 1,348 services; 2024 $111K for 1,938 services.
Medicare prescription drug claims, 2024
In 2024, the drug Terrence D Coulter prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 123 prescriptions and refills. In total Terrence D Coulter wrote 1,350 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 123 | 148 | 43 | $2,718 |
| Azithromycin Generic | 105 | 122 | 28 | $747 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 71 | 77 | Under 11 | $49K |
| Prednisone Generic | 69 | 93 | 31 | $189 |
| Symbicort Budesonide/Formoterol Fumarate | 64 | 86 | 16 | $20K |
| Breo Ellipta Fluticasone/Vilanterol | 54 | 54 | Under 11 | $21K |
| Roflumilast Generic | 53 | 61 | Under 11 | $2,779 |
| Spiriva Respimat Tiotropium Bromide | 39 | 59 | Under 11 | $31K |
| Armodafinil Generic | 36 | 36 | Under 11 | $822 |
| Eszopiclone Generic | 31 | 31 | Under 11 | $1,456 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 31 | 45 | Under 11 | $3,435 |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 31 | 36 | Under 11 | $1,890 |
| Prolastin C Alpha-1-Proteinase Inhibitor | 26 | 26 | Under 11 | $338K |
| Zolpidem Tartrate Generic | 26 | 34 | Under 11 | $185 |
| Ventolin Hfa Albuterol Sulfate | 24 | 24 | Under 11 | $1,357 |
Brand drugs: - claims; generic drugs: 748 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Terrence D Coulter $1,002 ($1,002 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $192.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $192 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69.22 |
| GlaxoSmithKline, LLC. GSK | 3 | $68.22 |
| Genzyme Corporation SNY | 2 | $68.14 |
| Insmed, Inc. INSM | 3 | $64.99 |
| Grifols USA, LLC | 3 | $60.22 |
| United Therapeutics Corporation UTHR | 2 | $53.67 |
| Merck Sharp & Dohme LLC MRK | 2 | $53.3 |
| Axsome Therapeutics, Inc. AXSM | 2 | $39.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.